发明名称 Drug releasing coatings for medical devices
摘要 The invention relates to a medical device for delivering a therapeutic agent to a tissue. The medical device has a layer overlying the exterior surface of the medical device. The layer contains a therapeutic agent, an antioxidant, and an additive. In certain embodiments, the additive has a hydrophilic part and a drug affinity part, wherein the drug affinity part is at least one of a hydrophobic part, a part that has an affinity to the therapeutic agent by hydrogen bonding, and a part that has an affinity to the therapeutic agent by van der Waals interactions. In some embodiments, the additive is a liquid. In other embodiments, the additive is at least one of a surfactant and a chemical compound, and the chemical compound has one or more hydroxyl, amino, carbonyl, carboxyl, acid, amide or ester groups.
申请公布号 US9005161(B2) 申请公布日期 2015.04.14
申请号 US201313846143 申请日期 2013.03.18
申请人 Lutonix, Inc. 发明人 Wang Lixiao
分类号 A61M31/00;A61L29/16;A61K31/337;A61K31/436;A61L31/16;A61L29/08 主分类号 A61M31/00
代理机构 Dinsmore & Shohl LLP 代理人 Dinsmore & Shohl LLP
主权项 1. A balloon catheter for delivering a therapeutic agent to a tissue, the balloon catheter being sterilized from exposure of the balloon catheter to ethylene oxide and comprising a coating layer overlying an exterior surface of a balloon, the coating layer comprising a therapeutic agent, an antioxidant and an additive, wherein: the therapeutic agent is chosen from paclitaxel, rapamycin, or combinations thereof; the antioxidant is butylated hydroxyanisole; the additive is chosen from PEG-20 sorbitan monooleate, PEG-20 sorbitan monolaurate, PEG-15 2-hydroxystearate, oleth-10, oleth-20, PEG-b-PLA, dioctyl sodium sulfosuccinate, sodium dodecyl sulfonate, polyvinylpyrrolidone, PEG-35 castor oil, sorbitol, lecithin, butyral trihexyl citrate, aleuritic acid, shellolic acid, or combinations thereof; and none of the therapeutic agent in the coating layer is hydrolyzed or oxidized.
地址 New Hope MN US